Joseph McCollom, DO
Hospice and Palliative Medicine · Fort Wayne, INNPI 1467717520
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $742 and has fallen 50.1% since, to $370 in 2025. Among hospice and palliative medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $41.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Histosonics, Inc.$317
- E.r. Squibb & Sons, L.L.C.$300
- Merck$250
- Seagen Inc.$170
- AstraZeneca$166
- Boston Scientific$155
- plus $2K from 28 others
What the payments were for
- Consulting fees$1204%
- Food & beverage$2,69193%
- Education$833%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Histosonics, Inc. | 1 | $317 |
| E.r. Squibb & Sons, L.L.C. | 5 | $300 |
| Merck | 9 | $250 |
| Seagen Inc. | 3 | $170 |
| AstraZeneca | 4 | $166 |
| Boston Scientific | 1 | $155 |
| Amgen | 4 | $138 |
| Bristol Myers Squibb | 1 | $136 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $136 |
| Acrotech Biopharma Inc. | 1 | $120 |
| Rigel Pharmaceuticals, Inc. | 2 | $115 |
| Johnson & Johnson | 4 | $104 |
| Genentech USA, Inc. | 1 | $102 |
| Incyte Corporation | 1 | $92 |
| Eisai Inc. | 5 | $66 |
| Exelixis Inc. | 3 | $58 |
| Sanofi | 3 | $51 |
| Pfizer | 2 | $46 |
| EMD Serono, Inc. | 2 | $43 |
| Pharmacosmos Therapeutics Inc. | 1 | $43 |
| AbbVie | 2 | $42 |
| Janssen Scientific Affairs, LLC | 1 | $35 |
| Tempus AI, Inc | 1 | $29 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Novartis | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Astellas Pharma Global Development | 1 | $15 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Dendreon Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,895 in reported general payments places this provider in the 95th percentile of 32 hospice and palliative medicine providers in Indiana.
See all hospice and palliative medicine providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LonsurfTrifluridine/Tipiracil Hcl | 39 | $326,768 |
| EliquisApixaban | 15 | $17,044 |
| Ondansetron OdtOndansetron | 81 | $2,113 |
| Olanzapine OdtOlanzapine | 31 | $1,576 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 73 | $971 |
| Dexamethasone | 112 | $920 |
| Prochlorperazine Maleate | 93 | $853 |
| Oxycodone Hcl | 56 | $495 |
| Gabapentin | 36 | $472 |
| Morphine Sulfate ErMorphine Sulfate | 19 | $419 |
| Methadone Hcl | 44 | $335 |
| Duloxetine Hcl | 15 | $329 |
| LoperamideLoperamide Hcl | 17 | $173 |
| Potassium Chloride | 16 | $147 |
| Sertraline Hcl | 38 | $135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $46 | $17,04415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 32 hospice and palliative medicine providers in Indiana.
Other hospice and palliative medicine in Fort Wayne
- Christina DrummondFort Wayne$458
- Syed AtherFort Wayne$161
- Alexandra OrtizFort Wayne$86
- Dona UncheseluFort Wayne$13
- David TribbleFort Wayne$12
- Anoush JidarianAvon$5K
- Angela WagnerIndianapolis$1K
- Lyle FettigIndianapolis$926
- Lauren GnagyDanville$413
- Jaswinder JalfDanville$346
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.